Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.
Saved in:
| Title: | Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors. |
|---|---|
| Authors: | Tusup M; University Hospital of Zürich, Department of Dermatology, Raemistrasse 100, 8091 Zürich, Switzerland; Faculty of Science, University of Zurich, Zürich, Switzerland., Kündig TM; University Hospital of Zürich, Department of Dermatology, Raemistrasse 100, 8091 Zürich, Switzerland; Faculty of Medicine, University of Zurich, Zürich, Switzerland., Pascolo S; University Hospital of Zürich, Department of Dermatology, Raemistrasse 100, 8091 Zürich, Switzerland; Faculty of Medicine, University of Zurich, Zürich, Switzerland. Electronic address: steve.pascolo@usz.ch. |
| Source: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 Mar 02; Vol. 30 (3), pp. 1163-1170. Date of Electronic Publication: 2021 Sep 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1525-0024 |
|---|---|
| DOI: | 10.1016/j.ymthe.2021.09.022 |
